Log In
Print
BCIQ
Print
Print this Print this
 

LX2761

  Manage Alerts
Collapse Summary General Information
Company Lexicon Pharmaceuticals Inc.
DescriptionSmall molecule sodium-glucose cotransporter 1 (SGLT1) inhibitor restricted to the intestine
Molecular Target Sodium-glucose cotransporter 1 (SGLT1)
Mechanism of ActionSodium-glucose cotransporter 1 (SGLT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today